SHARE PRICE: 2175.00 GBX
Log in Log in Learn More Learn More
The Craneware Group The Craneware Group
The Craneware Group The Craneware Group
  • Solutions

    Solutions

    Our applications and industry-leading team of experts contextualize operational, financial, and clinical data, providing insights that clearly demonstrate realistic revenue integrity and 340B compliance opportunities for our customers.

    Learn More Learn More
    • Solutions
    • Trisus
      • Trisus
      • Trisus eBook
    • Trisus Pricing Integrity Suite
      • Trisus Pricing Integrity Suite
      • Trisus Chargemaster
      • Trisus Pricing Analyzer and Transparency
      • Professional Services
      • Trisus® Reference
    • Trisus Business of Pharmacy Suite
      • Trisus Business of Pharmacy Suite
      • Trisus® Medication Analytic Solutions
      • Sentinel®
      • Sentrex®
      • Central Pharmacy Distribution (CDP)®
      • Professional Services
      • 340B Rebate Resource Center
      • From Policy to Performance: Trisus 340B Rebate
    • Trisus Healthcare Intelligence Suite
      • Trisus Healthcare Intelligence Suite
      • Trisus® Decision Support
      • Trisus® Labor Productivity
      • Professional Services
    • Trisus Data Integrity Suite
      • Trisus Data Integrity Suite
      • Trisus® Chargemaster
      • Trisus® Reference
      • Trisus® Medication Formulary
      • Trisus® Supply
      • Trisus® Supplies Assistant
      • Professional Services
  • News & Events

    News & Insights

    Read the latest news and learn about upcoming training and events with our industry leading experts.

    News & Insights News & Insights
    • News & Events
    • News & Insights
    • Events
      • Events
      • SUMMIT12
    • Press Releases
    • Publications
    • Webinars
  • Careers

    • Careers
    • Our Vacancies
    • Our Benefits
    • Our Story
    • Our Culture
    • Graduate Program
  • Company

    Company

    The Craneware Group is recognized as the leading provider of Revenue integrity and 340B management solutions that improve financial performance in the US hospital and health system markets. We’re respected as a healthcare business partner delivering value, quality, and outstanding customer service.

    Our Story Our Story
    • Company
    • Our Story
      • Our Story
      • Values
    • Governance
    • Investors
      • Investors
      • Why Invest
      • Reports
      • Investor Contacts
      • Shareholder Centre
      • AIM Rule 26
      • Advisors
      • AIM securities information
      • Possible Offer
    • Environmental, Social and Governance
    • Leadership
    • Board of Directors
    • Partners
Craneware
Log in Log in Learn More Learn More
SHARE PRICE: 2175.00 GBX
Craneware

Reports

  • Home
  • Company
  • Investors
  • Reports
  • Oct 2025

    Annual Report for the year ended 30 June 2025

    Download PDF PDF 1.7MB
  • Oct 2025

    Notice of AGM 2025 and Related Documents

    Download PDF PDF 389KB
  • Sep 2025

    Full Year Results 2025 Presentation

    Download PDF PDF 1.1MB
  • Sep 2025

    Full Year Results 2025

    Video
  • Aug 2025

    Shareholder Circular & Notice of General Meeting

    Download PDF PDF 349KB
  • Aug 2025

    Form of Proxy for General Meeting

    Download PDF PDF 176KB
  • Mar 2025

    Interim Report H1 2025

    Download PDF PDF 3.8MB
  • Mar 2025

    Interim Results 2025 Presentation

    Download PDF PDF 1.2MB
  • Mar 2025

    Interim results 2025

    Video
The Craneware Group

Solutions

  • Pricing
  • Revenue
  • Cost
  • 340B & Pharmacy
  • Services
  • Trisus

News & Events

  • Press Releases

Resources

    Company

    • Our Story
    • Governance
    • Investors
    • Careers
    • ESG

    Follow us

    • Twitter
    • LinkedIn
    © The Craneware Group. All rights reserved.
    • Security Statement
    • Privacy Policy
    • Legal
    • Modern Slavery Statement
    • Contact
    • Sitemap
    • Cookie Settings